Membrane proeteins as markers for normal and neoplastic endocrine cells by Lahr, G. et al.
C.Wagener S.Neumann ( E d s . ) 
Molecular Diagnostics 
of Cancer 
With 50 Figures and 31 Tables 
Springer-Verlag 
Berlin Heidelberg New York 
London Paris Tokyo 
Hong Kong Barcelona 
Budapest 
Professor Dr. Christoph Wagener 
Abteilung für Klinische Chemie, Medizinische Kl in ik 
Universi täts-Krankenhaus Eppendorf 
Martinistraße 52, W-2000 Hamburg 20, FRG 
Dr. Siegfried Neumann 
Diagnostische Forschung E. Merck 
Frankfurter Straße 250, W-6100 Darmstadt, FRG 
I S B N 3-540-55476-9 Springer-Verlag Ber l in Heidelberg New York 
ISBN 0-387-55476-9 Springer-Verlag New York Ber l in Heidelberg 
This work is subject to copyright. A l l rights are reserved, whether the whole or part of the material is concer-
ned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduc-
tion on microfilm or in any other way. and storage in data banks. Duplication of this publication or parts thereof 
is permitted only under the provisions of the G e r m a n Copyright L a w of September 9. 1%5. in its current ver-
sion, and permission for use must always be obtained from Springer-Verlag. Violations are liable for prosecu-
tion under the G e r m a n Copyright Law. 
'£< Springer-Verlag Berlin Heidelberg 1993 
Printed in Germany 
The use of general descriptive names, registered names, trademarks, etc. in this publication does not imply, 
even in the absence of a specific statement, that such names are exempt from the relevant protective laws and 
regulations and therefore free for general use. 
Product liability: T h e publishers cannot guarantee the accuracy of any information about dosage and applica-
tion contained in this book. In every individual case the user must check such information by consulting the 
relevant literature. 
Typesetting: Best-set Typesetter L t d . . Hong Konj 
27/3145-5 4 3 2 I 0 - Printed on acid-free paper 
Unlversitäts-
B i b ü o t h e k 
M ü n c h e n 
Contents 
The Polymerase Chain Reaction: 
Methodology and Diagnostic Potential (A. Pingoud) 1 
Gene Loss as Marker in Tumor Development: 
Considerations on the Origin of Specific Brain Tumors Due 
to Combinant Loss of Function Mutations 
of Tumor Suppressor Genes {K. D. Zang) 17 
p53: Oncogene, Tumor Suppressor, or Both? (W. Deppert) . . . . 27 
Tumor Genome Screening by Multilocus D N A Fingerprints 
as Obtained by Simple Repetitive Oligonucleotide Probes 
(J. T. Epplen, S. Bock, and P. Nürnberg) 41 
Activation of ras Oncogenes in Human Tumours 
(N. R. Lemoine) 53 
Laboratory Techniques in the Investigation 
of Human Papillomavirus Infection (E.-M. de Villiers) 65 
Detection of Minimal Residual Leukemia by Polymerase 
Chain Reactions (C. R. Bartram) 77 
A Dominant Metastogene Confers Metastatic Potential 
to Tumor Cells (H. Pont a, M. Zöller, K.-H. Heider, S. Seiter, 
W. Rudy, M. Hofmann, C. Tölg, and P Herrlich) 87 
Progression in Human Melanoma Is Accompanied 
by the Altered Expression of Cell Adhesion Molecules 
(/. P. Johnson, B. G. Stade, U. Rothbächer, S. Stratil, 
and G. Riethmüller) 97 
Structure, Function and Expression of the CEA Gene Family: 
Diagnostic and Therapeutic Implications (W. Zimmermann, 
F. Grunert, G. Nagel, S. von Kleist, and J. Thompson) 107 
V I I I Contents 
Membrane Proteins as Markers for Normal and Neoplastic 
Endocrine Cells (G. Lahr and M. Gratzl) 117 
Biological and Clinical Relevance of the Tumor-Associated 
Serine Protease uPA (M. Schmitt, E Jänicke, 
N. Chucholowski, L . Goretzki, N. Moniwa, E. Schüren, 
O. Wilhelm, and H. Graeff) 129 
Analysis of Growth Regulatory Pathways in Human 
Neuro-Oncology ( M . Westphal, W. Hamel, L . Anker, 
and H.-D. Herrmann) 151 
HER-2/Neu/c-ERB-B2 Amplification: Clinical Relevance 
in Mammary Carcinoma (W. Jonat, K. Friedrichs, 
H. Eidtmann, J. Meybohm, and S. Singh) 169 
Cytokine-Mediated Regulation of Growth Factor Receptors 
(EGF-R and erb-B2) in Pancreatic Tumors (H. Kalthoff, 
C. Roeder, and W. Schmiegel) 175 
Chimeric CEA-Specific Antibody Fragments and Anti-idiotypic 
Antibodies for Immunoscintigraphy and New Therapeutic 
Approaches to Colorectal Carcinomas (A/. Neumaier) 187 
Tumor Localization by Immunoscintigraphy: 
Potential and Limitations (S. Matzku and H. Bihl) 207 
Subject Index 219 
Contributors 
Anker, L . 1511 
Bartram, C R . 77 
Bihl , H . 207 
Bock, S. 41 
Chucholowski, N . 129 
Deppert, W. 27 
Eidtmann, H . 169 
Epplen,J .T. 41 
Friedrichs, K. 169 
Goretzki, L . 129 
Graeff, H . 129 
Gratzl, M . 117 
Grunert, F. 107 
Hamel, W. 151 
Heider, K . - H . 87 
Herrlich, P. 87 
Herrmann, H . - D . 151 
Hotmann, M . 87 
Jänicke, F. 129 
Johnson, J. P. 97 
Jonat,W. 169 
Kalthoff, H . 175 
Kleist, S. von 107 
Lahr, G. 117 
Lemoine, N.R. 53 
Matzku, S. 207 
Meybohm,J . 169 
Moniwa, N . 129 
Nagel, G. 107 
Neumaier, M . 187 
Nürnberg , P 41 
Pingoud, A . 1 
Ponta, H . 87 
Riethmüller, G. 97 
Roeder, C 175 
Rothbächer, U . 97 
Rudy, W. 87 
Schmiegel, W. 175 
Schmitt, M . 129 
Schüren, E. 129 
Seiter, S. 87 
Singh, S. 169 
Stade, B . G . 97 
Stratil, S. 97 
Thompson, J. 107 
Tölg, C 87 
Villiers, E . - M . de 65 
Westphal, M . 151 
Wilhelm, O. 129 
Zang, K . D . 17 
Zimmermann, W. 107 
Zöller, M . 87 
* The addresses of the authors are given on the first page of each contribution. 
1 Page on which contribution begins. 
Membrane Proteins as Markers for Normal 
and Neoplastic Endocrine Cells 
Georgia Lahr and Manfred Gratzl 
Abteilung Anatomie und Zellbiologie, Universität U l m , Albert-Einstein-Allee 11, 
W-7900 U l m , FRG 
Introduction 
Neurons, endocrine cells and their neoplastic derivatives share a variety 
of similar or even identical characteristic proteins. The analysis of these 
cellular constituents provides valuable information on the nature, location 
and distribution of tumor cells in the body. 
Neuron-specific enolase, a soluble cytoplasmic glycolytic enzyme, was the 
first widely used marker protein for neural and endocrine cells and serves 
as an excellent diagnostic tool in neurologic and endocrine disease [22]. 
Recently, specific secretory products of endocrine cells, the chromogranins/ 
secretogranins, which are costored and coreleased with catecholamines and 
peptide hormones, have also attracted interest as neural or endocine cell 
markers. These markers can be measured in tumor tissue or cells and also in 
serum [15, 36, 37, 41]. 
In addition to the proteins mentioned above, intracellular membrane 
proteins or constituents of the plasma membrane have very recently been 
accepted as diagnostic markers. One group of intracellular membrane pro-
teins common to neural and endocrine cells is found in small translucent 
vesicles (SVs). In neurons SVs contain transmitters and are thus termed 
synaptic vesicles [6, 16]. In endocrine cells the function of SVs, which 
contain the same membrane proteins as synaptic vesicles, is unknown. I f 
SVs in endocrine cells also contain transmitters, they could reflect the 
existence of a second secretory pathway in addition to the well-characterized 
release of peptide hormones from large, dense core vesicles (LVs) by 
exocytosis. 
Cell surface antigens shared by neural and endocrine cells have also been 
identified. For example, the neural cell adhesion molecules (NCAMs), have 
been found in peptide hormone- as well as steroid hormone-producing 
endocrine cells. Moreover, N C A M expression characterizes the cell-cell 
adhesion specificities between these cells [18-21, 23, 27]. In addition, 
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NCAMs have been found in a variety of rodent and human endocrine tumor 
cells, suggesting a possible application as markers [ 1 , 2, 9, 10, 13, 17-19, 21, 
24, 26, 31]. 
In this chapter we will depict the structure and function of synaptophysin, 
as an example of a SV membrane protein already used as an endocrine 
tumor marker, and describe the molecular and cell biology of NCAMs, a 
recently elucidated group of membrane antigens present in normal and 
neoplastic endocrine cells. 
Structure and Function of Synaptophysin 
Neurotransmission between a presynaptic nerve terminal and postsynaptic 
target cell involves discharge of transmitter molecules. The neurotransmitters 
are stored in specialized organelles, the synaptic vesicles. The specific func-
tion of synaptic vesicles includes uptake and storage of neurotransmitters, 
interaction with the cytoskeleton, docking and fusion with the plasma mem-
brane. Synaptophysin [6, 16] is one of the major integral membrane proteins 
of SVs (average diameter 50nm). In the SV membrane it forms hexamers, 
composed of identical subunits of 38kDa, whose primary structure has been 
elucidated by sequencing rat, cow and human cDNA. Synaptophysin is a 
highly conserved protein consisting of four transmembrane domains as well 
as short N-terminal and extended C-terminal cytoplasmic domains (Fig. 1). 
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Fig. 1. Schematic representation of the synaptophysin mRNA illustrating the 
positions of the protein domains coded by the different exons. Exons are represented 
by the white boxes. The start (ATG) and stop (TAA) codons for translation are also 
indicated. The other boxes are explained at the foot of the figure. The positions of 
nucleotides are given in the lower panel 
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Synaptophysin incorporated into lipid membranes exhibits voltage-
dependent channel activity [39] and it may dock to a complementary protein, 
physophilin, a component of the presynaptic plasma membrane, possibly 
initiating formation of a fusion pore and subsequent neurotransmitter 
release [38]. 
Isolation and comparison of the complete rat and human synaptophysin 
genes showed that, despite the difference in molecular size (16kb in rat vs 
13 kb in man), intron/exon boundaries are precisely conserved [3]. Exon 7, 
because of a stop codon in exon 6, is not translated in either species (Fig. 1). 
The 5' upstream region is devoid of any T A T A or CA A T boxes but 
is characterized instead by features typical of "housekeeping" genes. 
Specifically, GC-rich islands and four Spl-binding motifs indicate that 
synaptophysin synthesis is regulated at the transcriptional level. Sequences 
more than 1.2 kb downstream from the immediate upstream region may be 
responsible for cell type-specific expression of synaptophysin. 
Molecular and Cell Biology of Neural Cell Adhesion Molecules 
Cell-cell adhesion molecules (CAMs) - the ligands or receptors involved in 
cell-cell contact formation - are important regulators of cell assembly and 
maintenance of tissue architecture. 
The NCAMs are among the most prevalent CAMs in vertebrates. They 
are glycoproteins anchored in different ways to the plasma membrane and 
promote cell-cell adhesion through a homophilic binding mechanism. The 
different NCAMs are primary translation products arising through alterna-
tive splicing of a single gene located on human chromosome 11 and mouse 
chromosome 9. They have similar extracellular domains but differ primarily 
in their plasma membrane associated and intracellular domains. For 
example, NCAM-180 (the isoform having a molecular weight of 180kDa) 
contains a cytoplasmic domain which is larger than that of NCAM-140. By 
contrast, NCAM-120 consists only of extracellular domains and is linked to 
the plasma membrane by a phosphatidylinositol anchor (Fig. 2). 
Alternative splicing can allow the fine modulation of gene expression such 
that protein isoforms with functional differences are expressed in the proper 
spatiotemporal fashion. It is a posttranscriptional process by which pre-
mRNA transcribed from the gene can code a variety of protein isoforms that 
differ in function or localization. Twenty major exons in both mammals 
and birds code for the different N C A M isoforms. While exon O encodes 
the 5'-untranslated and leader sequences [33], exons 1-14 generate the 
extracellular sequences of all known NCAMs (Fig. 2). Exon 15 codes for 
the membrane-anchoring sequence of NCAM-120, and exon 18 codes for 
the additional cytoplasmic insert unique to NCAM-180 [4, 5, 25, 32]. 
Recently, additional exons in the N C A M gene have been discovered. 
They can be added at the exon 12/13, 13/14 junction, thereby coding for the 
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Fig. 2. Scheme of the protein and exon structure of the neural cell adhesion 
molecule with a molecular weight of 140 kDa (NCAM-140). The N - and C-termini of 
the protein are indicated. Loops I-V represent the disulfide-linked loop structures of 
the immunoglobulin-like domains. The inset explains the symbols used in the upper 
panel. The plasma membrane is indicated by the dotted box. NCAM-120 contains the 
translation product of exon 15 which is attached to the membrane via a 
phosphatidylinositol anchor. The sequence coded by exon 18 which is unique to 
NCAM-180 is shown at the right side of the schema. Minor exons are indicated by 
VASE, a and AAG. In the lower panel the exons of NC A M are represented as boxes. 
The characteristic exons of NCAM-120 and NCAM-180 are marked in addition to 
exon 0, which is not translated. The alternatively spliced minor ^extra-exons" at 
exon junctions 7/8 and 12/13 are also shown. The V marks indicate alternative splice 
junctions 
hinge region of the molecule, or at the exon 7/8 junction. Genomic cloning 
revealed that three smaller exons of 15, 48 and 42bp could be positioned 
between exons 12 and 13 [8, 28, 40]. Furthermore, an exon named SEC, 
which contains a stop codon generating a secreted N C A M form, has been 
spliced into this position [11]. A 15-nt exon (a 15) with or without an 
additional A A G triplet has also been detected between exon 12 and exon 
13 [33]. It is not clear whether the 3'-terminal A A G triplet is encoded by 
a 3-nt exon [33]. A n A A G triplet has also been found at the exon 13/14 
junction ( D . Bartheis et al. 1991, personal communication). From the 
examples given above it is obvious that the hinge region of the NCAMs 
can be modified by alternative splicing in many ways. The functional 
consequences of these insertions are as yet unknown. The structure of 
the N-terminal extracellular regions of NCAMs contains five domains which 
are similar to each other and to the homology units of immunoglobulins. 
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Thus NCAMs, like other cell adhesion molecules such as L I , F l , contactin, 
TAG-1 and M A G , are members of the immunoglobulin superfamily. 
A heparin-binding domain has been identified in the second 
immunoglobulin-like domain of NCAMs. Additionally, an N-linked oligo-
saccharide has been mapped to the third immunoglobulin-like domain which 
is engaged in the autoadhesion between NCAMs of neighboring cells. It is 
the adjacent fourth immunoglobulin-like loop of NCAMs which can be 
varied by alternative splicing. A 30-nt exon, termed pi or VASE (variable 
alternatively spliced exon), is located between exons 7 and 8 [33, 35]; 
it has been suggested that VASE may modify binding affinity [34]. Taken 
together, 198 different mRNA species could code for N C A M polypeptides 
( D . Bartheis et al. 1991, personal communication) [30, 33]. The presence of 
extra exons in cellular mRNA can be detected using SI nuclease protection 
assays. This method allows direct comparison of mRNA and labeled D N A 
or RNA probe sequences. The SI nuclease hydrolyzes only single-stranded 
D N A and RNA probes. Thus, if the D N A or RNA probe does not pair 
precisely, tails or loops not protected by hybridization to the mRNA will be 
excised. Resolution of the undigested Sl-protected fragments of the probes 
on denaturing Polyacrylamide gels yields detailed information about the 
regions of sequence homology between the probe and the mRNA (Fig. 3). 
The fifth extracellular loop of NCAMs is subject to functionally important 
posttranslational nodification. Though NCAMs have multiple carbohydrate 
attachment sites, modulation of adhesion specifically arises from differences 
in the length of homopolymers of alpha-2, 8-linked neuraminic acid units 
(polysialic acid, PSA) linked to NCAMs via a core carbohydrate. NCAMs 
occur in highly sialylated embryonic and less sialylated adult forms. The 
precise molecular mechanism whereby polysialic acid on NCAMs modulates 
the calcium-independent autoadhesion remains to be analyzed, but it is clear 
that enzymatic removal of PSA increases binding between NCAM-bearing 
liposomes and neuroblastoma cells [29]. 
Following transient expression in various embryonic structures, NCAMs 
are subsequently found predominantly in adult neural, endocrine, skeletal 
and cardiac muscle cells. Available data imply that NCAMs influence a 
number of developmental processes such as segregation of cells into discrete 
regions, axon guidance and formation and innervation of skeletal muscle [4, 
5, 23, 25, 32]. 
Regulation of gene expression can occur at the transcriptional, post-
trancriptional, translational and posttranslational levels as developmental 
processes unfold. Regulation at the transcription level is initiated by the 
promoter region of the gene. It should be noted that the N C A M promoter 
does not contain a typical T A T A box, and therefore initiation of RNA 
transcription occurs at several sites on the gene; this initiation mechanism 
is often observed in genes that lack this sequence. Sequences for both 
promotion and inhibition of transcription reside within 840 bp upstream of 
the main transcription start site. In this upstream region a juxtaposition 
122 G. Lahr and M . Gratzl 
7 
6 7 VASE 
m R N A s 
—• c 
> C 
cDNA or cRNA probe 
Hybr id i za t i on a n d S1 n u c l e a s e ( ^ ) d i g e s t i o n 
A 
mRNA with VASE 
B 
mRNA without VASE 
/ I 6 | 7 [VAig l 8 " Z 7 
/ T T 1 7 
protected fragment 
protected fragments 
d e n a t u r i n g 
P o l y a c r y l -
a m i d e ge l 
p r A B 
Fig. 3. Detection of additional exons in N C A M mRNA by SI nuclease protection 
assays. The exons of two different mRNAs as well as the labeled c D N A or cRNA 
probe with additional vector sequences used are shown at the top. The probe is 
hybridized with the mRNAs with (A) or without (B) exon V A S E followed by SI 
nuclease digestion, which hydrolyzes all single-stranded regions (indicated by the 
arrows). In A only the vector sequences are removed, whereas in B the single strand 
coding for extra-exon VASE contained in the labeled probe wil l be totally digested 
by SI nuclease, leaving two protected fragments. The samples are run on a 
denaturing Polyacrylamide gel to determine the size of probe fragments protected 
from the SI nuclease by hybridization 
of a Spl factor-binding consensus site and a nuclear factor I-binding site 
has been mapped. Moreover, motifs, such as three A + T-rich segments 
containing A T T A motifs and an A G G A repeat which resembles negative 
regulatory elements in other promoters, were also mapped. It seems that 
negative and positive elements in the promoter, with features typical of 
"housekeeping1' genes, interact to regulate the tissue-specific pattern of 
N C A M gene expression. Furthermore, a factor related to nuclear factor I is 
involved in transcriptional control of the N C A M gene [14]. 
Expression of Synaptophysin and N C A M s in Normal and Neoplastic 
Endocrine Cells 
The distribution of synaptophysin and NCAMs in normal and neoplastic 
endocrine cells is summarized in Table 1. In addition to their occurrence in 
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Table 1. Occurrence of the antigen of small secretory vesicles, synaptophysin (SYN), 
and of the neural cell adhesion molecules (NCAMs) in normal and neoplastic 
endocrine cells and tissues 
Tissues Cells and tumors SYN NCAMs 
Adenohypophysis Normal endocrine cells + + 
Adenoma + + 
Adrenal medulla Normal chromaffin cells + + 
Pheochromocytoma + + 
Adrenal cortex Normal steroid-producing cells - + 
Cortical carcinoma n.d. + 
Bronchial tract Normal endocrine cells + n.d. 
Small cell carcinoma + + 
Carcinoid + n.d. 
Gastrointestinal tract Normal enteroendocrine cells + n.d. 
Carcinoid + n.d. 
Pancreas Normal islet cells + + 
Adenoma + n.d. 
Parathyroid Normal chief cells + n.d. 
Adenoma + n.d. 
Thyroid Normal C cells + n.d. 
C-cell carcinoma + n.d. 
Testis Leydig cells n.d. + 
Ovary Granulosa and luteal cells n.d. + 
n.d., not determined. 
catecholamine- and peptide hormone-containing cells, NCAMs have also 
been detected in steroid-producing cells of adrenal cortex [27] and ovarian 
granulosa and luteal cells [23]. The potential application of N C A M analysis 
in tumors derived from these tissues can be envisioned, based on a report of 
N C A M expression in an adrenocortical carcinoma [17]. Synaptophysin, on 
the other hand, occurs in all normal peptidergic endocrine cells and in 
neoplasms derived from these cells (Table 1). 
A variety of different techniques has been applied in the analysis of 
synaptophysin and NCAMs in normal and neoplastic endocrine cells. These 
analytical techniques provide precise descriptions of the extent of transcrip-
tion, translation and even posttranslational modification of cellular membrane 
proteins. For example, transciption is analysed using in situ hybridization 
and Northern blot techniques in addition to the more sophisticated SI 
nuclease protection assays, described above, which can elucidate the 
sequence of a specific mRNA. Insights into translation of synaptophysin and 
NCAMs in particular cells are provided by light and ultrastructural immuno-
cytochemistry. These morphological techniques, in conjunction with 
immunological techniques such as Western blotting, can be utilized to 
analyze the anatomical arrangements related to posttranslational processing 
or modification (e.g. proteolytic modification, presence of PSA and others). 
Taken together, these techniques have been used to define the nature of 
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certain primary tumors and, importantly, to detect their metastases. It is 
also possible to identify neoplastic cells which express endocrine marker 
proteins in mixed tumors. For example, cell heterogeneity is a prominent 
characteristic in most lung neoplasms. Yet, in mixed tumors as well as 
in homogeneous tumors immunocytochemical techniques reveal different 
cell types based on their expression of NCAM-140; specifically, small cell 
carcinoma cells express NCAM-140 while mesotheliomas and squamous cell 
carcinomas do not [2, 9, 21, 24, 26]. Differential diagnosis of the lung 
tumors based on their expression of cell markers provides important insights 
for prognosis and therapy. 
Detection of synaptophysin (like neuron-specific enolase) can certainly be 
regarded as a general tool to distinguish endocrine from nonendocrine 
tumor cells. NCAMs share with other endocrine markers the property of 
differential expression in endocrine tumor cells. For example, all pituitary 
adenomas, characterized by hormone markers [2], have been found to 
contain synaptophysin and neuron-specific enolase, but NCAM-140, the 
prevalent isoform in normal and neoplastic endocrine tumor cells, was not 
detected by immunoblotting in prolactinomas, suggesting that it is minimally 
expressed in this cell type [2]. In like manner, chromogranin A , a protein 
costored and coreleased from a variety of peptide hormone-producing cells, 
has not been observed in all their neoplasms. While prolactinomas do 
not appear to contain chromogranin A [7], they can be identified by 
their hormone content and the expression of synaptophysin and neuron-
specific enolase. Adenomas not expressing hormones, termed inactive 
adenomas, generally express the latter markers together with NCAM-140 
and chromogranin A ; on the other hand, analysis of the hormones in serum 
or by immunocytochemistry in these adenomas is not of diagnostic value [2, 
7, 12]. 
The examples given above clearly demonstrate that analysis of membrane 
markers for endocrine tumor cells provides important contributions to a 
precise (differential) diagnosis and elucidation of the biological properties of 
the neoplastic cells even though they differ in their degrees of proliferation 
and their tendencies to form metastases. Thus, membrane marker charac-
terizations form an important basis for therapeutic design and modulation of 
its effect. 
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